APE fundamentals
An in-depth look to ADDEX THERAPEUTICS LTD operating, investing, and financing activities
APE free cash flow for Q3 24 is -424.29 k EUR. For 2023, APE free cash flow was -8.56 M EUR and operating cash flow was -8.56 M EUR.
Q1 '06
Q2 '06
Q4 '06
Q1 '07
Q2 '07
Q4 '07
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '06
Q2 '06
Q4 '06
Q1 '07
Q2 '07
Q4 '07
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM